Clinical Trial

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-18; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2025-12-15
Trial Details
NCT Number NCT07187297
Lead Sponsor Bausch Health Americas, Inc.
Conditions Wrinkle, Lax Skin, Lines Skin
Enrollment 164 participants
Start Date 2025-10-31
Primary Completion 2026-06 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-17